Resection margin involvement and tumour origin in pancreatic head cancer.
about
Validation of full-field optical coherence tomography in distinguishing malignant and benign tissue in resected pancreatic cancer specimens.Whipple made simple for surgical pathologists: orientation, dissection, and sampling of pancreaticoduodenectomy specimens for a more practical and accurate evaluation of pancreatic, distal common bile duct, and ampullary tumors.Intensity of follow-up after pancreatic cancer resectionThe Association between Survival and the Pathologic Features of Periampullary Tumors Varies over Time.Current and future intraoperative imaging strategies to increase radical resection rates in pancreatic cancer surgery.COX-2 overexpression in resected pancreatic head adenocarcinomas correlates with favourable prognosis.Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal originAdjuvant radiotherapy and chemoradiation with gemcitabine after R1 resection in patients with pancreatic adenocarcinoma.Long-term survival after resection for non-pancreatic periampullary cancer followed by adjuvant intra-arterial chemotherapy and concomitant radiotherapy.Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.Feasibility and reliability of pancreatic cancer staging using a new confocal non-fluorescent microscopy probe: a double-blind study in rats.Minimally invasive versus open pancreatoduodenectomy-systematic review and meta-analysis.Innovations in macroscopic evaluation of pancreatic specimens and radiologic correlation.Resection margins in pancreatic cancer: are we entering a new era?Friday, February 21, 2014, 5:00pm–6:30pm Oral Poster I (Liver I, II; Pancreas I, II; Biliary I; Transplant I; Other)Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.Use of a standardized diagnostic approach improves the prognostic information of histopathologic factors in pancreatic and periampullary adenocarcinoma.Is there a 'margin' for error in pancreatic cancer surgery?Resection margins in pancreatic cancer.National assessment of margin status as a quality indicator after pancreatic cancer surgery.Histological and Molecular Subclassification of Pancreatic and Nonpancreatic Periampullary Cancers: Implications for (Neo) Adjuvant Systemic Treatment.Meta-analysis of radical resection rates and margin assessment in pancreatic cancer.Outcome and evaluation of prognostic factors after pancreaticoduodenectomy for distal cholangiocarcinoma.UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept.Survival outcome and prognostic factors after pancreatoduodenectomy for distal bile duct carcinoma: a retrospective multicenter study.Redefining the R1 resection in patients with pancreatic ductal adenocarcinoma.Intraoperative blood loss is not a predictor of prognosis for pancreatic cancer.Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma.Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort studyInformation needs among patients and a surveillance strategy after surgery for pancreatic and periampullary cancerMesopancreas: A boundless structure, namely the rationale for dissection of the paraaortic area in pancreaticoduodenectomy for pancreatic head carcinoma.Augmented reality-guided artery-first pancreatico-duodenectomy.Intestinal-type and pancreatobiliary-type adenocarcinomas: how does ampullary carcinoma differ from other periampullary malignancies?Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer.Surgical margins for duodenopancreatectomy.Preoperative Therapy and Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: a 25-Year Single-Institution Experience.Dilemmas for the pathologist in the oncologic assessment of pancreatoduodenectomy specimens : An overview of different grossing approaches and the relevance of the histopathological characteristics in the oncologic assessment of pancreatoduodenectomIntraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer.
P2860
Q33570699-CA3AAD85-0199-450E-981D-51C056161BB1Q33732158-4FAE1E0D-7E58-4BA3-A893-C91A753453C6Q33791048-21273AFB-F517-476B-AAA0-880A10B02FE3Q33914755-27FC35A3-6353-4E4D-8B28-91826529C619Q34009539-A37CE36D-49DC-4DF9-B25D-294C63C51CE3Q34502422-7C09F299-E5B1-45AF-B750-B18BBB88F8C1Q34992861-DA64D11F-8F72-4C6B-8037-C9EA0EBD5138Q35504794-0434E276-47AD-4563-9B87-586D8150FEF9Q35761091-B269821B-38AF-4BC1-915A-985A060194B8Q36055277-7EFA6658-8013-4870-8F12-142427405330Q36063416-7CD9AF59-7A0B-45E3-BBF2-D3E3E6591315Q36367512-12F56958-4D12-43E8-8690-15FF7DCD587CQ36740066-34221F2A-3033-4210-9A11-3BE9D57E0D7BQ37480810-303F9826-67C5-454D-B03A-8A35EC61B5A1Q37480826-2D358BC4-23BA-4860-AF71-C892119B8C84Q37538915-2614AB99-F6FB-46E9-8B5C-03C7BC7B625FQ37722822-30F11ABB-CB2D-4FE3-A00C-AADAF0B6591CQ38068490-62B66369-59F8-443D-8E05-228FDDE57686Q38160324-E65A00A6-5758-4511-BE16-B48B468A80B0Q38171293-71973C43-7C26-48E1-AFE0-93E16A09173BQ38287286-EE5D6061-13EA-4AC2-9114-76BA74757F30Q38582990-ADE96CAE-2870-4E7B-BE32-5A8C6E06E297Q38606303-0E6D1CB7-B766-4AE2-9E98-2D84E14340B9Q38649239-B8814CE6-FB65-4DE1-8C85-CD3B1CC9B307Q38726733-9C9579CB-E93B-43DC-875C-9A4668BAC3BDQ38927638-07D235AB-342B-48A0-940E-626098CE7056Q38971297-77725BEE-1B47-4C34-B9EE-2BA966B4669CQ41491695-223BFA90-9C64-4F4D-83A4-88C355C00857Q41545288-6084D027-DD5E-43D5-9A2E-A94712829E78Q42416964-5216585A-4CA6-49FC-8B93-7B662CF10967Q43183747-F868B38A-E21C-4FC7-964C-7C10BAB1E9A6Q44574799-58889036-4C39-4871-B4D7-1BA41BC2E76AQ45307308-DED74BCD-F7EC-4C4F-B0CB-0748E22D2F09Q47124313-F1FC39AD-F8CA-4CDC-8BE8-E61344BD3A0CQ48278023-838F72DF-75C8-46CE-B7E6-4E3EC0A5DB4DQ51751748-BB86E5EE-BD38-4EAD-BD3C-7593186544B9Q52339747-66D14CBA-9CB1-4424-B785-16917203F79BQ52581499-399DBE90-DB16-4C20-B5CD-D9075E235B1AQ52840594-14303C0A-EFF4-4AA5-BBD6-46C0ADFDCE05
P2860
Resection margin involvement and tumour origin in pancreatic head cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Resection margin involvement and tumour origin in pancreatic head cancer.
@en
type
label
Resection margin involvement and tumour origin in pancreatic head cancer.
@en
prefLabel
Resection margin involvement and tumour origin in pancreatic head cancer.
@en
P2860
P356
P1476
Resection margin involvement and tumour origin in pancreatic head cancer.
@en
P2093
C S Verbeke
P2860
P304
P356
10.1002/BJS.8734
P407
P577
2012-04-20T00:00:00Z